サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：動静脈瘻（AVF）デバイスの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年
市場調査レポート
商品コード
1321412

動静脈瘻（AVF）デバイスの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年

Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report By Type (AVF Creation Devices, AVF Monitoring Devices, AVF Maintenance Devices), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
動静脈瘻（AVF）デバイスの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年07月20日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動静脈瘻（AVF）デバイス市場の成長と動向

Grand View Research社の最新レポートによると、動静脈瘻（AVF）デバイスの世界市場規模は2030年までに5億5,660万米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 7.6％で成長すると予測されています。AVFは動脈と静脈の異常な接続であり、先天性要因、外傷、外科的処置によって生じる可能性があります。これらの異常な接続は、四肢と肝臓や脳を含む内臓の両方で頻繁に観察されます。医療においては、血液透析を必要とする末期腎不全（ESRD）患者のために、AVFが意図的に造設されます。AVFを作ることで、医療プロバイダーは、効率的な透析治療のために、血流への信頼できる永続的なアクセスポイントを確立することができます。

AVFデバイスの市場は、血液透析を必要とするESRDの有病率の上昇を含むいくつかの要因によって牽引されており、AVFは透析治療のための信頼性の高い血管アクセスを提供するために作成されます。さらに、血管内治療や塞栓術などの低侵襲手技の進歩がAVFデバイスの需要を促進しています。

主なプレーヤーは、市場での優位性を高めるために、買収、合併、提携、強力な研究開発活動などの戦略的イニシアチブを積極的に実施しています。これらのイニシアチブは、製品ポートフォリオを強化し、市場でのプレゼンスを拡大し、AVFデバイス技術の革新を推進することを目的としています。

例えば、VentureMed Groupは2022年5月、「Flex Vessel Prep before PTA for the treatment of obstructive lesions in the native AVF」と名付けられた無作為化比較試験（RCT）の登録を完了しました。この臨床試験は、上肢AVFの閉塞性病変を治療するために、経皮経管血管形成術（PTA）前にFlex Vessel Prepシステムを使用することで、PTA単独と比較して6ヵ月後の一次開存性を評価するように設計されています。このような研究イニシアチブは、臨床的エビデンスを生み出し、AVFデバイスの有効性と安全性を実証する上で重要な役割を果たします。

したがって、企業が研究開発に投資することで、AVFの開存性を高め、合併症を最小限に抑え、AVF患者に優れたソリューションを提供する革新的なデバイスの導入が期待できます。

AVFデバイス市場レポートハイライト

  • 2022年、作製セグメントは46.97%の最大収益シェアを占めました。作製セグメントは、AVF処置を効果的かつ成功させ、最適な透析治療を可能にし、患者の転帰を改善する上で重要な役割を果たしています。革新的な作製技術や技術の進歩は、成功率の向上、合併症の減少、患者ケアの向上をもたらし、このセグメントの成長をさらに後押ししています。
  • 2022年には、病院セグメントが54.20%と最大の収益シェアを占めました。この優位性は、高度なインフラ、熟練した医療専門家の利用可能性、病院でのAVFデバイスの利用をさらに促進する償還制度へのアクセスなどの要因に起因します。
  • 2022年には、北米が47.59%と圧倒的な収益シェアを占めました。この大きな市場シェアは主に、同地域でESRDの有病率が増加し、透析治療の需要が高まり、効果的なAVFデバイスのニーズが生まれたことに起因しています。
  • 主な市場プレイヤーは、Medtronic、BD、Teleflex Incorporated、Fresenius Medical Care AG &Co.KGaA.、B. Braun SE、Polymedicure、NxStage Medical, Inc.、Laminate Medical Technologiesなどです。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 地域の範囲
  • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
  • 情報分析
  • 市場の形成とデータの視覚化
  • モデル詳細
  • 二次情報のリスト

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場動向と展望
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 事業環境分析
    • PESTLE分析
    • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 タイプのビジネス分析

  • AVFデバイス市場：タイプの変動分析、2022年および2030年
  • 作製
  • モニタリング
  • メンテナンス

第5章 最終用途のビジネス分析

  • AVFデバイス市場：最終用途の変動分析、2022年および2030年
  • 病院
  • 外来手術センター
  • 透析センター

第6章 地域のビジネス分析

  • 地域の市場スナップショット
  • 北米
    • 北米のAVFデバイス市場
    • 米国
    • カナダ
  • 欧州
    • 欧州のAVFデバイス市場
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋のAVFデバイス市場
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカのAVFデバイス市場
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカのAVFデバイス市場
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業の分類
  • 戦略マッピング
    • 取得
    • コラボレーション
    • 新しいプラットフォームの発表
    • その他
  • 企業プロファイル・一覧表
    • BD
    • Medtronic
    • Teleflex Incorporated
    • Fresenius Medical Care AG &Co. KGaA
    • Polymedicure
    • NxStage Medical, Inc
    • Laminate Medical Technologies
    • B. Braun SE
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global Arteriovenous Fistulas (AVF) devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 16 Germany Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 18 UK Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 20 France Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 22 Italy Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 24 Spain Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 26 Denmark Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 28 Sweden Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 30 Norway Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 China Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 34 China Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Japan Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 36 Japan Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 38 India Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 42 Australia Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 44 Thailand Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 46 Latin America Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 47 Latin America Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Brazil Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 49 Brazil Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Mexico Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 51 Mexico Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Argentina Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 53 Argentina Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Africa Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Africa Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 UAE Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 61 UAE Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Arteriovenous fistulas (AVF) devices market segmentation
  • Fig. 7 Market snapshot, 2022
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis (current & future impact)
  • Fig. 10 Market restraint relevance analysis (current & future impact)
  • Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Global Arteriovenous Fistulas (AVF) devices market: Type Outlook Key Takeaways
  • Fig. 14 Global Arteriovenous Fistulas (AVF) devices market: Type Movement Analysis
  • Fig. 15 Global AVF creation devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 16 Global AVF monitoring devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 17 Global AVF maintenance devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Arteriovenous Fistulas (AVF) devices market: End-use Outlook Key Takeaways
  • Fig. 19 Global Arteriovenous Fistulas (AVF) devices market: End-use Movement Analysis
  • Fig. 20 Global hospital market, 2018 - 2030 (USD Million)
  • Fig. 21 Global ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 22 Global dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 23 Regional Marketplace: Key Takeaways
  • Fig. 24 Regional outlook, 2022 & 2030
  • Fig. 25 Global Arteriovenous Fistulas (AVF) devices market: Regional Movement Analysis
  • Fig. 26 North America Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 32 France Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 40 China Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 41 India Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-099-5

AV Fistula Devices Market Growth & Trends

The global AV fistula devices market size is expected to reach USD 556.6 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.6% from 2023 to 2030. AVFs are abnormal connections between arteries and veins, which can arise from congenital factors, trauma, or surgical procedures. These abnormal connections are frequently observed in both limbs and internal organs, including the liver and brain. In the context of healthcare, AVFs are deliberately established for patients suffering from End-stage Renal Disease (ESRD) who necessitate hemodialysis. By creating AVFs, healthcare providers can establish a dependable and enduring access point to the bloodstream for efficient dialysis treatments.

The market for arteriovenous fistula (AVF) devices is driven by several factors, including the rising prevalence of ESRD necessitating hemodialysis, where AVFs are created to provide reliable vascular access for dialysis treatments. In addition, advancements in minimally invasive procedures, such as endovascular techniques and embolization, have fueled the demand for AVF devices.

Key players are actively implementing strategic initiatives, including acquisitions, mergers, collaborations, and robust research and development activities, to enhance their market dominance. These initiatives aim to strengthen their product portfolios, expand their market presence, and drive innovation in AVF device technologies.

For instance, in May 2022 VentureMed Group completed the enrollment of a Randomized Controlled Trial (RCT) named 'Flex Vessel Prep before PTA for the treatment of obstructive lesions in the native AVF.' This clinical trial was designed to evaluate the primary patency at six months by utilizing the Flex Vessel Prep system before Percutaneous Transluminal Angioplasty (PTA), compared to PTA alone, for treating obstructive lesions in native AVFs in the upper extremity. Such research initiatives play a crucial role in generating clinical evidence and demonstrating the efficacy and safety of AVF devices.

Thus, as companies invest in research and development, the market can expect the introduction of innovative devices that enhance AVF patency, minimize complications, and provide superior solutions for patients with AVFs.

AV Fistulas Devices Market Report Highlights

  • In 2022, the AVF creation devices segment held the largest revenue share of 46.97%. AVF creation devices play a crucial role in enabling effective and successful AVF procedures, allowing for optimal dialysis treatment and improving patient outcomes. The advancement of innovative AVF creation technologies and techniques further drives the growth of this segment, as they offer improved success rates, reduced complications, and enhanced patient care
  • In 2022, the hospital segment held the largest revenue share of 54.20%. This dominance can be attributed to the factors such as the availability of advanced infrastructure, skilled healthcare professionals, and access to reimbursement systems that further fuel the utilization of AVF devices in hospitals
  • In 2022, North America held the dominant revenue share of 47.59%. This significant market share is primarily attributed to the increasing prevalence of ESRD in the region has led to a higher demand for dialysis treatment, creating a need for effective AVF devices
  • Key market players include Medtronic; BD; Teleflex Incorporated; Fresenius Medical Care AG & Co. KGaA., B. Braun SE; Polymedicure; NxStage Medical, Inc.; and Laminate Medical Technologies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Arteriovenous Fistulas Device (AVF) Market: Type Movement Analysis, 2022 & 2030
  • 4.2. AVF Creation Devices
    • 4.2.1. AVF Creation Devices Market, 2018 - 2030 (USD Million)
      • 4.2.1.1. Surgical Instruments
      • 4.2.1.1.1. Surgical Instruments Market, 2018 - 2030 (USD Million)
      • 4.2.1.2. Vascular Grafts
      • 4.2.1.2.1. Vascular Grafts Market, 2018 - 2030 (USD Million)
      • 4.2.1.3. Angioplasty Balloons
      • 4.2.1.3.1. Angioplasty Balloons Market, 2018 - 2030 (USD Million)
      • 4.2.1.4. Others
      • 4.2.1.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. AVF Monitoring Devices
    • 4.3.1. AVF Monitoring Devices Market, 2018 - 2030 (USD Million)
      • 4.3.1.1. Doppler Ultrasound
      • 4.3.1.1.1. Doppler Ultrasound Market, 2018 - 2030 (USD Million)
      • 4.3.1.2. Pressure Monitoring Systems
      • 4.3.1.2.1. Pressure Monitoring Systems Market, 2018 - 2030 (USD Million)
      • 4.3.1.3. Others
      • 4.3.1.3.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. AVF Maintenance Devices
    • 4.4.1. AVF Maintenance Devices Market, 2018 - 2030 (USD Million)
      • 4.4.1.1. Central Venous Catheters
      • 4.4.1.1.1. Central Venous Catheters Market, 2018 - 2030 (USD Million)
      • 4.4.1.2. Stents
      • 4.4.1.2.1. Stents Market, 2018 - 2030 (USD Million)
      • 4.4.1.3. Others
      • 4.4.1.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Arteriovenous Fistulas Device (AVF) Market: End-use Movement Analysis, 2022 & 2030
  • 5.2. Hospitals
    • 5.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 5.4. Dialysis Centers
    • 5.4.1. Dialysis Centers Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. Competitive Scenario
    • 6.2.3. Canada
      • 6.2.3.1. Canada Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Competitive Scenario
  • 6.3. Europe
    • 6.3.1. Europe Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Germany Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Competitive Scenario
    • 6.3.3. UK
      • 6.3.3.1. UK Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Competitive Scenario
    • 6.3.4. France
      • 6.3.4.1. France Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Competitive Scenario
    • 6.3.5. Italy
      • 6.3.5.1. Italy Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Competitive Scenario
    • 6.3.6. Spain
      • 6.3.6.1. Spain Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Competitive Scenario
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Competitive Scenario
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Competitive Scenario
    • 6.3.9. Norway
      • 6.3.9.1. Norway Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Competitive Scenario
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Competitive Scenario
    • 6.4.3. China
      • 6.4.3.1. China Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Competitive Scenario
    • 6.4.4. India
      • 6.4.4.1. India Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Competitive Scenario
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Competitive Scenario
    • 6.4.6. Australia
      • 6.4.6.1. Australia Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Competitive Scenario
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Competitive Scenario
  • 6.5. Latin America
    • 6.5.1. Latin America Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Competitive Scenario
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Competitive Scenario
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Competitive Scenario
  • 6.6. MEA
    • 6.6.1. MEA Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Competitive Scenario
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Competitive Scenario
    • 6.6.4. UAE
      • 6.6.4.1. UAE Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Competitive Scenario
    • 6.6.5. Kuwait
      • 6.6.5.1. UAE Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Acquisition
    • 7.2.2. Collaborations
    • 7.2.3. New Platform Launches
    • 7.2.4. Others
  • 7.3. Company Profiles/Listing
    • 7.3.1. BD
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Platform Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Medtronic
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Platform Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Teleflex Incorporated
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Platform Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Fresenius Medical Care AG & Co. KGaA
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Platform Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Polymedicure
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Platform Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. NxStage Medical, Inc
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Platform Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Laminate Medical Technologies
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Platform Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. B. Braun SE
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Platform Benchmarking
      • 7.3.8.4. Strategic Initiatives